Merz to acquire BioForm Medical

San Mateo, Calif. — German pharmaceutical company Merz Pharma Group will acquire BioForm Medical, based here, for $253 million in cash, news source Modern Healthcare reports.

January 13, 2010

1 Min Read
The Aesthetic Guide logo in a gray background | The Aesthetic Guide

San Mateo, Calif. — German pharmaceutical company Merz Pharma Group will acquire BioForm Medical, based here, for $253 million in cash, news source Modern Healthcare reports.

BioForm’s products include dermal fillers and a developmental injectable treatment for varicose veins. According to a company press release, BioForm reported about $66 million in revenue for the fiscal year ending June 30, 2009, and expects to generate between $64 million and $70 million in its current fiscal year.

The transaction has been approved by both companies’ boards of directors and will likely close during 2010’s first quarter.

Subscribe to receive the latest in aesthetic medicine.
Get breaking developments, expert product comparisons, clinical roundtables, and practice strategies—all for free.